Avanos Medical, Inc. reported $716M of revenue over the trailing twelve months, +3.9% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $716M (to Q1 2026). Net income: −$74M, trailing twelve months to Q1 2026. Free cash flow: $7.5M, trailing twelve months to Q1 2026. Operating margin: −9.1%, trailing twelve months to Q1 2026.

AVNSAvanos Medical, Inc.

Healthcare

$24.99+114% 1Y

$24.99

$9.8952 weeks$25.05

AVNS as reported

Avanos Medical, Inc. reported $716M of revenue over the trailing twelve months, +3.9% on the year before. 11 reported series are charted on this page, each one as filed.

$716M

Revenue, trailing twelve months · to Q1 2026 · +3.9% against the twelve months before

Net income: −$74M
Net income · −81% year on year · trailing twelve months to Q1 2026
Free cash flow: $7.5M
Free cash flow · −93% year on year · trailing twelve months to Q1 2026
Operating margin: −9.1%
Operating margin · trailing twelve months to Q1 2026

Details›

Every series Ryufin has for AVNS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$716M	+3.9%	Q1 2026
Net income	−$74M	−81%	Q1 2026
EPS	−$1.60	−81%	Q1 2026
Gross margin	50%	n/a	Q1 2026
Operating margin	−9.1%	n/a	Q1 2026
Net margin	−11%	n/a	Q1 2026
ROE	−35%	n/a	Q1 2026
ROA	−26%	n/a	Q1 2026
ROIC	−27%	n/a	Q1 2026
Free cash flow	$7.5M	−93%	Q1 2026
P/E	56.0	n/a	Q1 2019 · 28 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.